Navigation
banner
Together we Drive the Future

Stem Cell Research & Regenerative Medicine

2017-02-212017-03-092017-02-13
EARLY BIRD DISCOUNT! Register by Mar 09, 2017 to receive 10% off your registration!
Or register 3 for the price of 2 with the coupon code rcdvb!


registration button

Stem Cell Summit


Stem Cell Research & Regenerative Medicine

Stem Cell Product Development & Commercialization
 
 

Dear Colleague,

We welcome you to GTCbio’s 14th Stem Cell Research & Regenerative Medicine Conference. This conference presents information regarding cutting-edge developments in all areas of stem cell research, including the biology, medicine, applications and regulations of stem cells. Topics of discussion include recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine, stem cell reprogramming, immunotherapy, cell therapy in diabetes, and regulatory policies regarding stem cell research.

 

Session Topics:

  1. Advances in Adult & Pluripotent Stem Cell Research
  2. Revolution in Immunotherapy
  3. Translation to the Clinic: What’s in the Pipeline
  4. Joint Plenary Session: Where do We Stand with Cell Therapy in Diabetes?

 

This conference is part of the Stem Cell Summit taking place April 5-7, 2017 in Boston, MA which includes two back-to-back conferences:

April 5-6, 2017: 14th Stem Cell Research & Regenerative Medicine Conference
April 6-7, 2017: 6th Stem Cell Product Development & Commercialization Conference

We look forward to seeing you at the conference!

 

Best regards,

The 2017 Advisory Committee

 

2017 Advisory Board Members
Stephen Chang, The New York Stem Cell Foundation
Douglas Losordo, Caladrius Biosciences
Robert Deans, BlueRock Therapeutics
Alain Vertes, GmbH
Daniel Anderson, Massachusetts Institute of Technology
Edward Lanphier, Sangamo Biosciences
Khalid Shah, Harvard Medical School; Massachusetts General Hospital
Yang (Ted) Teng, Harvard University & The Brigham and Women’s Hospital
Anthony Ting, Athersys
James Ankrum, University of Iowa
Hardy T S Kagimoto, Healios K.K (RIKEN Venture)
Robert Halliwell, University of the Pacific
Devyn Smith, Pfizer
Jiwen Zhang, GE Healthcare
Julie G. Allickson, Wake Forest Institute for Regenerative Medicine
Tiina Palomaki, Finnish Medicines Agency
Satish Medicetty , GTCbio